CPAP treatments for sleep apnea have the potential to reduce dementia risk, a new study reports.
TRPM7 plays a role in suppressing breathing in obese mice with symptoms of sleep apnea.
Reboxetine, a selective norepinephrine reuptake inhibitor normally prescribed for depression, can reduce sleep apnea symptom severity.
People who snore and those with obstructive sleep apnea tend to be less active during the day.
Using CPAP to treat sleep apnea could help improve cognitive decline symptoms in older adults with mild cognitive impairment.
Obstructive sleep apnea may impact your behavior when driving, a new study reports. People with sleep apnea who experienced eight additional disruptions in breathing per hour had a 27% increased risk of making dangerous driving moves, such as speeding, hard breaking , or accelerating suddenly.
Sulthiame, a CA inhibitor drug, reduced the number of breathing pauses and promoted oxygenation during the night in sufferers of obstructive sleep apnea.
Untreated obstructive sleep apnea can accelerate biological aging, but treating OSA can slow or even reverse the process.
Sleep apnea during pregnancy may increase the risk of brain and behavioral changes associated with autism in males, a new study reports.
People who suffer from insomnia in conjunction with sleep apnea are more likely to experience heart problems and are 50% more likely to die than those without the conditions.
Two existing medications have been repurposed to treat sleep apnea. Researchers report the medications reduce symptoms of sleep apnea by 30%.
Children who snore while they sleep have thinner gray matter in several areas of the frontal lobes. Significantly, the reduction in gray matter correlated with behavioral problems associated with sleep apnea. Some behavioral problems experienced include hyperactivity, increased aggression, and attention deficits.
